Factors associated with willingness to take extended release naltrexone among injection drug users.

March 2, 2016

CONCLUSIONS: A high level of willingness to take XR-NTX was observed in this setting. Interestingly, daily injection heroin use was positively associated with willingness, whereas Caucasian participants were less willing to take XR-NTX. Although explanations for unwillingness were described in this study, further research is needed to investigate real-world acceptability of XR-NTX as an additional […]

Read the full article →

A retrospective evaluation of inpatient transfer from high-dose methadone to buprenorphine substitution therapy

March 2, 2016

The product license of buprenorphine/naloxone for opioid substitution therapy indicates reducing methadone concentrations to 30 mg or less per day for a minimum of 1 week before transferring patients to buprenorphine and no sooner than 24 hours after the last methadone dose, because of the risk of precipitated withdrawal and a corresponding high risk of […]

Read the full article →

Budgetary impact of the utilization of buprenorphine/naloxone sublingual film and tablet for Medicaid in the United States

March 2, 2016

Journal of Medical Economics, Ahead of Print. (Source: Journal of Medical Economics)

Read the full article →

The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and Wales

March 2, 2016

Conclusions Our analysis of the relative safety of buprenorphine and methadone for opioid substitution treatment reveals that buprenorphine is six times safer than methadone with regard to overdose risk among the general population. Clinicians should be aware of the increased risk of prescribing methadone, and tighter regulations are needed to prevent its diversion. (Source: BMJ […]

Read the full article →

5 Ways We Can Reduce Drug Overdoses

March 2, 2016

Fatal drug overdose has reached epidemic levels in the U.S., surpassing vehicle-related deaths in 36 states, according to a new report from the Trust for America’s Health and Robert Wood Johnson Foundation. In a separate study, researchers found that drug overdoses in the United States tripled in the last 25 years. The two-fold tragedy of […]

Read the full article →

What was the drug Dylann Roof had when arrested in February?

March 2, 2016

Opioid drug Suboxone, designed for addiction treatment, is becoming more common on the street (Source: Health News: CBSNews.com)

Read the full article →

A case of rhabdomyolysis associated with severe opioid withdrawal.

March 2, 2016

CONCLUSION: A review of the literature was completed on severe cases of precipitated and spontaneous opioid withdrawal followed by a discussion of the significance as it relates to this case. SCIENTIFIC SIGNIFICANCE: Given the widespread use of prescription opioids and opioid maintenance treatment, physicians should be aware of the complications of acute opioid withdrawal and […]

Read the full article →

Suboxone: What is it?

March 2, 2016

(Source: CNN.com – Health)

Read the full article →

Evaluation of an inpatient medical withdrawal program in rural Ontario: a 1-year prospective study.

March 2, 2016

CONCLUSION: The MWSS shows positive outcomes for many clients, their families and communities. Clients returned to work and school, became more engaged in healthy meal preparation and exercise, spent more time with family and were more involved as leaders in their communities. PMID: 26160514 [PubMed – in process] (Source: Canadian Journal of Rural Medicine) MedWorm […]

Read the full article →

BUPRENORPHINE HCL AND NALOXONE HCL (Buprenorphine And Naloxone) Tablet [Mallinckrodt, Inc.]

March 2, 2016

Updated Date: Aug 13, 2015 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Read the full article →

← Previous Entries

Next Entries →